RANGAP1 and gastric cancer: Prognostic models showed that plasma exosomal circ-RanGAP1 combined with TNM staging was more effective in assessing GC prognosis, with the AUC of 0.830 compared to 0.646 for plasma exosomal circ-RanGAP1 and 0.779 for TNM staging.